Phenylisobutylamine

Phenylisobutylamine is a psychoactive drug and research chemical of the phenethylamine and amphetamine chemical classes. It acts as a non-neurotoxic and highly selective dopamine releasing agent (DRA) with negligible effects on norepinephrine and serotonin pathways. The drug is primarily used in scientific research.

Chemistry[edit | edit source]

Phenylisobutylamine, also known as α-ethylphenethylamine, is a synthetic molecule of the amphetamine family. Molecules of this class contain a phenethylamine core featuring a phenyl ring bound to an amino (NH2) group through an ethyl chain with an additional methyl substitution at Rα.

Pharmacology[edit | edit source]

Phenylisobutylamine is a releasing agent, or "releaser," primarily of dopamine, a potent neurotransmitter. It has negligible effects on norepinephrine and serotonin release. Phenylisobutylamine, like other amphetamines, is able to induce euphoria, enhance alertness, increase concentration, and promote a feeling of well-being.

Effects[edit | edit source]

The effects of phenylisobutylamine are similar to those of other amphetamines. These effects include euphoria, increased alertness and wakefulness, increased energy and motivation, increased concentration, and improved mood. However, it can also cause a range of negative side effects, including anxiety, paranoia, and insomnia.

Legal Status[edit | edit source]

The legal status of phenylisobutylamine varies by country, but it is generally considered a controlled substance under many national drug laws due to its potential for abuse and addiction.